Mitochondrial Dysfunction in Cancer

• Published in: Frontiers in oncology Vol. 3; p. 292
• Main Authors: Boland, Michelle L., Chourasia, Aparajita H., Macleod, Kay F.
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 02.12.2013
• Subjects: Biogenesis; Cancer Metabolism; cell cycle control; Mitochondria; mitophagy; Oncology; Oxidative Phosphorylation; cancer metabolism; mitophagy; mitochondria; cell cycle control; mitochondrial fusion and fission; mitochondrial biogenesis; oxidative phosphorylation
• ISSN: 2234-943X; 2234-943X
• DOI: 10.3389/fonc.2013.00292

A mechanistic understanding of how mitochondrial dysfunction contributes to cell growth and tumorigenesis is emerging beyond Warburg as an area of research that is under-explored in terms of its significance for clinical management of cancer. Work discussed in this review focuses less on the Warburg effect and more on mitochondria and how dysfunctional mitochondria modulate cell cycle, gene expression, metabolism, cell viability, and other established aspects of cell growth and stress responses. There is increasing evidence that key oncogenes and tumor suppressors modulate mitochondrial dynamics through important signaling pathways and that mitochondrial mass and function vary between tumors and individuals but the significance of these events for cancer are not fully appreciated. We explore the interplay between key molecules involved in mitochondrial fission and fusion and in apoptosis, as well as in mitophagy, biogenesis, and spatial dynamics of mitochondria and consider how these distinct mechanisms are coordinated in response to physiological stresses such as hypoxia and nutrient deprivation. Importantly, we examine how deregulation of these processes in cancer has knock on effects for cell proliferation and growth. We define major forms of mitochondrial dysfunction and address the extent to which the functional consequences of such dysfunction can be determined and exploited for cancer diagnosis and treatment.